Johnson & Johnson is one of the largest healthcare and consumer product companies in the world, employing 136,500 people. Revenues of between $88-90 billion are expected for 2021. Its three divisions comprise Consumer, Pharmaceutical, and Medical Devices.
JNJ Symbol Info by TradingView
Wealth BuilderSorry, you do not have access to this content.
Income InvestorSorry, you do not have access to this content.
Having more than tripled since our original recommendation, and up 6% in the last year against a 14% fall in the S&P 500, JNJ remains a Buy for its strong balance sheet, steady high single-digit growth in earnings, and reasonable dividend. - Gavin Graham
Consult your broker/advisor
JNJ Charts & Fundamental Data by TradingView